M&A Deal Summary

RIV Capital Acquires Etain

On March 30, 2022, RIV Capital acquired consumer products company Etain for 247M USD

Acquisition Highlights
  • This is RIV Capital’s 1st transaction in the Consumer Products sector.
  • This is RIV Capital’s largest (disclosed) transaction.
  • This is RIV Capital’s 1st transaction in the United States.
  • This is RIV Capital’s 1st transaction in New York.

M&A Deal Summary

Date 2022-03-30
Target Etain
Sector Consumer Products
Buyer(s) RIV Capital
Deal Type Add-on Acquisition
Deal Value 247M USD
Advisor(s) Moelis & Co. (Financial)
DLA Piper (Legal)

Target

Etain

New York, New York, United States
Etain is a family-run, women-owned, and operated medical marijuana company that crafts medical marijuana products. Etain was formed in 2015 and is based in New York, New York.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

RIV Capital

Toronto, Ontario, Canada

Category Company
Founded 2017
Sector Business Services
Revenue 7M USD (2023)
DESCRIPTION

RIV Capital is an operating and brand platform that aims to acquire, invest in, and develop U.S. cannabis companies to build the cannabis industry of tomorrow, today. By bringing together people, capital, and ideas, the company aims to provide shareholders with exposure to exceptional cannabis companies in strategically attractive states poised for significant growth. Backed by in-house expertise and cannabis domain knowledge, it aims to develop operators and brands who can build market share while expanding the geographic and strategic scope of the multistate platform. RIV Capital was incorporated in 2017 and is headquartered in Toronto, Ontario.


DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1